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The purpose of the studies in this paper was to evaluate the allergic potential, immunotoxicity, and irritancy of the occupationally
relevant chemical, 1-chloro-4-(triﬂuoromethyl)benzene, also known as parachlorobenzotriﬂuoride (PCBTF), following dermal
exposure in a murine model. Evaluation of the sensitization potential, conducted using the local lymph node assay (LLNA) at
concentrations ranging from 50% to 100%, identiﬁed a dose-dependent increase in lymphocyte proliferation with a calculated
EC3 value of 53.1%. While no elevations in total or speciﬁc IgE were observed after exposure to any concentration of the
chemical, signiﬁcant increases in IFN-γ protein production by stimulated draining lymphoid cells were observed, indicating a
T-cell-mediated response. Dermal exposure to PCBTF was not found to alter the immune response to a T-cell-dependant antigen.
These results demonstrate that PCBTF has the potential to induce allergic sensitization following dermal exposure and based on
LLNA results would be classiﬁed as a weak sensitizer.
1.Introduction
1-Chloro-4-(triﬂuoromethyl)benzene, a ﬂuorinated toluene,
also known as parachlorobenzotriﬂuoride (PCBTF), is a
chemical used as an intermediate in a wide range of organic
reactions for the synthesis of dyes, pharmaceuticals, pesti-
cides, insecticides and herbicides [1]. It is primarily used as
a solvent in commercial surface ﬁnishes, such as vapor de-
greasing,precisionwipecleaning,coldcleaningandelectron-
ics cleaning, and is manufactured in both pure and blended
formulations based upon speciﬁc cleaning requirements
[2, 3]. It is also used as an ink solvent in the printing
industry and is a component(5–12%)of low volatile organic
compound (VOC) compliant polyurethane ﬁnishes. PCBTF
is not considered to be an air toxin or ozone depleter. It
has therefore recently been considered exempt from VOC
regulations [4], which has led to an increase in its use as a
replacement for other solvents previously used in the man-
ufacture of a variety of commercially-available paints, inks,
and other products and ﬁnishes (Oxsol 100, Occidental
Chemical Co.) [1].
PCBTF was recently nominated by the National Toxicol-
ogy Program (NTP) for toxicologicalcharacterization due to
itsunknownchronic toxicityproﬁleandchangesinitsindus-
trial and consumer use [1]. In addition, its improper use or
disposal may lead to an increase in public exposure outside
of the occupational context. There are currently no Occu-
pational Safety & Health Administration (OSHA), National
Institute for Occupational Safety and Health (NIOSH), or
AmericanConferenceofGovernmentalIndustrialHygienists
(ACGIH) limits regulating PCBTF exposure [1].
AlthoughthehealtheﬀectsofPCBTFhavenotbeenthor-
oughly tested, epidemiological studies in workers have re-
ported increases in respiratory and stomach cancers [5].
Animal studies investigating the health eﬀects of PCBTF
exposure are limited. In a 13-week inhalational study in rats,
no changes were identiﬁed in any measured clinical chem-
istry parameter, at doses up to 252ppm, and no adverse2 Journal of Allergy
Cl
F
F F
Figure 1: Chemical structure of PCBTF.
observations were recorded during exposures or during
detailed weekly clinical evaluations [6]. Subchronic studies
were negative for precancerous hematological changes and
other histopathological indicators of carcinogenicity [7].
However, exposure to PCBTF did increase relative liver
weights between dose groups. Subchronic inhalational and
oral exposure to higher concentrations of PCBTF in rats
produced clinical signs of toxicity that included salivation,
tremors, altered hematological, and hepatocellular proﬁles
[7]. These signs, however, were only noted at 1000mg/kg/
day, which is greatly outside of the range expected in a
potential spill of PCBTF-containing paint products. PCBTF
has low subchronic oral toxicity as well, and neither patho-
logical nor adverse biochemical eﬀects were found at doses
up to 10mg/kg/day, which have been described as the no-
observable-eﬀect level of PCBTF [8].
Although it is a primary route of occupational exposure,
very few dermal exposure studies have been conducted on
this chemical [2]. In addition, immunotoxicological studies
are lacking. The recent increase in occupational use, along
with the potential for dermal exposure warrants the eval-
uation of the immunotoxicity of PCBTF following dermal
exposure.
2.MaterialandMethods
2.1. Test Articles and Chemicals. 1-Chloro-4-(triﬂuorometh-
yl)benzene (98%) (PCBTF; Figure 1) [CAS no. 98-56-6],
alpha-hexylcinnamaldehyde (HCA) [CAS no. 101-86-0],
2,4-dinitroﬂuorobenzene (DNFB) [CAS no. 70-34-8],
toluene 2,4-diisocyanate (TDI, CAS 584-84-9) and cyclo-
phosphamide [CAS no. 50-18-0] were all purchased from
Aldrich Chemical Company, Inc. (Milwaukee, Wis).
2.2. Species Selection. Female BALB/c and B6C3F1 mice
were used in these studies. BALB/c mice have a Th2
bias and are commonly used to evaluate potential IgE-
mediated sensitization. They were therefore used in the
hypersensitivity studies[9,10].B6C3F1micearethestrainof
choice for immunotoxicity studies and were used to evaluate
the IgM response to SRBC [11]. The mice were purchased
from Taconic (Germantown, NY) at 6–8 weeks of age. Upon
arrival, theanimals wereallowedtoacclimateforaminimum
of 5 days. Each shipment of animals was randomly assigned
to a treatment group, weighed, and individually identiﬁed
via tail marking using a permanent marker. A preliminary
analysisofvarianceonbodyweightswasperformedtoensure
a homogeneous distribution of animals across treatment
groups. The animals were housed at a maximum of 5 per
cage in ventilated plastic shoebox cages with hardwood
chip bedding. NIH-31 modiﬁed 6% irradiated rodent diet
(Harlan Teklad), and tap water was provided from water
bottles,adlibitum.Thetemperatureintheanimal facilitywas
maintained between 68 and 72◦Fa n dt h er e l a t i v eh u m i d i t y
between36and57%.Thelight/darkcyclewasmaintained on
12-hour intervals. Allanimal experiments were performed in
theAAALACaccreditedNIOSHanimalfacilityinaccordance
with an animal protocol approved by the Institutional
Animal Care and Use Committee.
2.3. Concentration Range Finding Studies. Concentration
rangeﬁndingstudieswereperformed toselecttheconcentra-
tions of PCBTF to be used for dermal exposures. BALB/c
mice were exposed topically to acetone vehicle or increasing
concentrations of PCBTF up to 100% in acetone on the dor-
sal surface of each ear (25μL per ear) for three consecutive
days. Animals were allowed to rest for 2 days following the
l a s te x p o s u r ea n dt h e nw e i g h e da n de x a m i n e df o rs i g n so f
toxicity, such as loss of body weight, fatigue/lack of activity,
and ungroomed fur. The maximum concentration selected
for the subsequent studies was based on limits of toxicity.
2.4. Combined Local Lymph Node and Irritancy Assay. To
determinetheirritancy and sensitization potentialofPCBTF,
a combined local lymph node assay (LLNA) was conducted.
PCBTF dosing concentrations (50–100%) and vehicle (ace-
tone) were selected based on solubility and preliminary
concentration range ﬁnding studies. The LLNA was per-
formed according to the method described in the ICCVAM
Peer Review Panel report (1999) with minor modiﬁcations
[12]. Brieﬂy, mice (5 per group) were topically treated with
acetone vehicle, increasing concentrations of PCBTF, or
positive control(30%alpha-hexylcinnamaldehyde; HCA)on
the dorsal surface of each ear (25μL per ear) once a day
forthreeconsecutivedays.2,4-dinitroﬂuorobenzene(DNFB)
was used as a positive control for irritancy. Irritancy mea-
surements were performed as previously described [13]. The
thickness of the right and left ear pinnae of each mouse was
measured using a modiﬁed engineer’smicrometer(Mitutoyo
Co.) before the ﬁrst chemical administration and 24 hours
following the ﬁnal exposure. The mean percentage of ear
swelling was calculated based on the following equation:
[(mean postchallenge ear thickness − mean prechallenge
ear thickness)/mean prechallenge thickness] × 100. Animals
were allowed to rest for 2 days following the last exposure.
On day 6 mice were injected intravenously, via the lateral
tail vein, with 20μCi 3H-thymidine (Dupont NEN; speciﬁc
activity2Ci/mmol).Fivehoursafter 3H-thymidineinjection,
animals were euthanized via CO2 inhalation, and the left
and right superﬁcial parotid draining lymph nodes (DLNs),
located at the bifurcation of the jugular vein, were excised
and pooled for each animal. Single cell suspensions were
made and incubated overnight in 5% trichloroacetic acid
(TCA), and samples were counted using a Packard Tri-
Carb 2500TR liquid scintillation analyzer (Perkin Elmer).
Stimulation indices (SI) were calculated by dividing the
mean disintegrations per minute (DPM) per test group byJournal of Allergy 3
the mean DPM for the vehicle control group. EC3 values
(concentration of chemical required to induce a 3-fold
increase over the vehicle control) were calculated based on
the equations from Basketter et al. [14].
2.5. Phenotypic Analysis of Lymphocytes. Lymphocyte phe-
notypes were analyzed using ﬂow cytometry as described
by Manetz and Meade [15]. For the phenotypic analysis,
mice were topically exposed to acetone or increasing con-
centrations of PCBTF (up to 100%) on the dorsal surface
of each ear (25μL per ear) once a day for four consecutive
days. Animals were allowed to rest for 6 days after the ﬁnal
treatment and then euthanized on day 10 by CO2 inhalation.
Animals were weighed and examined for gross pathology
at the end of the experiment. The following organs were
removed, cleaned of connective tissue and weighed: liver,
spleen,kidneys,andthymus. DLNs(twonodes/animal/tube)
and spleens were also collected separately in 3mL PBS
and were dissociated using the frosted ends of two micro-
scope slides. Cell counts were performed using a Coulter
Counter (Z2 model, Beckman Coulter), and 1 × 106 cells
per sample were added to the wells of a 96-well plate.
Cells were washed using staining buﬀer (1% bovine serum
albumin/0.1% sodium azide in PBS) and then incubated
with Fc block (clone 2.4G2). For IgE+/B220+ analysis, the
cells were incubated with anti-CD45RA/B220 (PE, clone
RA3-6B2) and anti-IgE antibodies (FITC, clone R-35-72)
or appropriate isotype control diluted in staining buﬀer.
For analysis of T-cell subsets, cells were incubated with
anti-mouse CD3e antibody (APC, clone 145-2C11), anti-
mouse CD4 antibody (FITC, clone RM4-5), and anti-mouse
CD8a antibody (PE, clone 53-6.7) or the appropriate isotype
controls diluted 1:100 in staining buﬀer. All antibodies and
isotype controls were purchased from BD Pharmingen. Cells
werethenwashedandincubatedwithpropidiumiodide(PI).
After a ﬁnal wash, cells were resuspended in staining buﬀer
and analyzed with a Becton Dickinson FACSCalibur ﬂow
cytometer using a PI viability gate.
2.6. Total Serum IgE. For analysis of total IgE, PCBTF was
tested at concentrations up to 100%. Mice were treated
with acetone, increasing concentrations of PCBTF, or, as a
positive control, 1.5% TDI on the dorsal surface of each
ear (25μL per ear) once a day for four consecutive days.
Animals were allowed to rest for 6 days after the ﬁnal
treatment and were euthanized onday 10 by CO2 inhalation.
Following euthanasia, blood samples were collected via
cardiac puncture. Sera were separated by centrifugation
(10min at 10,000×g) and frozen at −20◦Cf o rn e x td a y
analysis of IgE by ELISA. A standard colorimetric sandwich
ELISA was performed as previously described [16]. All
antibodies and isotype controls were purchased from BD
Pharmingen. In brief, 96-well ﬂat bottom plates (Dynatech
Immulon-2) were coated with puriﬁed monoclonal rat anti-
mouse IgE antibody (clone R35-72; 2μg/mL, diluted in
0.05M carbonate-bicarbonate buﬀer, pH 9.6), sealed with
platesealers, andincubatedovernightat4◦C.Theplateswere
washed 3 times with PBS/Tween 20 and then blocked for
1 hour with diluent (2% fetal bovine serum (FBS; Hyclone
Laboratories, Inc., Logan, Utah) and 0.05% sodium azide)
at room temperature. Serum samples were diluted 1:10
in diluent and IgE control standards (mouse IgE anti-
TNP, clone C38-2) were prepared (highest concentration:
500ng/mL). The diluted serum samples and IgE control
standards were then serially diluted (1:2) through 8 wells,
added to the coated plates in a 100μL volume and incubated
at room temperature for 1 hour. The plates were washed 3
times with PBS/0.05% Tween 20. Biotin-conjugated rat anti-
mouse IgE (clone R35-92; 2μg/mL) was added in a 100μL
volume and plates were incubated at room temperature for 1
hour. The plates were then washed 3 times with PBS/0.05%
Tween 20. Streptavidin-alkaline phosphatase was added
(100μL of a 1:400 in diluent) and plates were incubated
for 1 hour at room temperature. P-Nitrophenyl phosphate
(Sigma) was used as the alkaline phosphatase substrate and
added to the plates in a 100μL volume. The plates were
allowed to developforupto30minutes atroomtemperature
or until the optical density (OD) reading of the highest
standard reached 3.0. Absorbance was determined using a
Spectramax Vmax plate reader (Molecular Devices) at 405–
605nm. Dataanalysis was performed using theIBMSoftmax
Pro 3.1 (Molecular Devices), and the IgE concentrations for
each sample were interpolated from a standard curve using
multipoint analysis.
2.7. Analysis of Cytokine Production by Draining Lymph Node
Cells. To determine cytokine protein production by lym-
phocytes, DLNs of mice used for the analysis of total IgE
were collected (two nodes/animal/tube) in 2mL PBS and
dissociated using the frosted ends of two microscope slides.
Cell counts were performed using a Coulter Counter (Z1
model, Beckman Coulter), and cells were adjusted to 1 ×
106 cells/mL using sterile RPMI media containing 10% FBS.
Cells were added to a 48-well plate in a 500μLv o l u m e ,
stimulated with α-CD3 and α-CD28 (2μg/mL of each; BD
Pharmingen) and incubated for 24 hours at 37◦Ca n d
5% CO2. Supernatants were analyzed for IL-4 and IFN-
γ production using an OptEIA ELISA kit purchased from
BDBiosciencesaccording tothemanufacturer’s instructions.
Supernatants collected from each culture (2 stimulated and
2 unstimulated for each mouse) were added to the plates
in triplicate along with serial dilutions of the standards.
Plates were read at 450nm [OD values for standards ranging
from 0.77–1.93] using a SpectraMax M2 spectrophotometer
(Molecular Devices). Cytokine concentration was extrapo-
lated from the standard curve. The ﬁnal data are expressed as
the mean value generated when the concentration identiﬁed
for the unstimulated cultures was subtracted from the value
generated from the stimulated cultures for each mouse.
2.8. In Vivo IgM Response to the T-Cell-Dependent Antigen,
SRBC. The primary IgM response to sheep red blood cells
(SRBC) was enumerated using a modiﬁed hemolytic plaque
assay of Jerne and Nordin [17]. B6C3F1 mice were dermally
exposed to PCBTF (6–100%) for 14 days (25μL/ear). Four
days prior to euthanasia (day 11), the mice were immunized4 Journal of Allergy
with 7.5 × 107 SRBC by intravenous injection in a 200μL
volume. All SRBC for these studies were drawn from
a single donor animal (Lampire Laboratories, Pipersville,
Penn). On the day of sacriﬁce, mice were euthanized by
CO2 asphyxiation, body and organ weights were recorded
and spleens were collected in 3mL of Hanks Balanced Salt
Solution (HBSS). Single cell suspensions of the spleens from
individual animals were prepared in HBSS by disrupting
the spleen between the frosted ends of microscopic slides.
To identify the total number of spleen cells, 20μL of cells
were added to 10mL of isoton buﬀer (1:500) and two drops
of Zap-o-globin were added to lyse red blood cells. Cells
were then counted using a Coulter counter. 1:30 and 1:120
dilutions of spleen cells were made. One hundred μLo f
the dilutions were added to a test tube containing a 0.5mL
warm agar/dextran mixture (0.5% Bacto-Agar, DIFCO; and
0.05% DEAE dextran, Sigma), 25μLo f1:1r a t i oo fS R B C
suspension, and 25μL of 1:4 dilution (1mL lyophilized)
guinea pig complement (Cedarlane Labs). Each sample was
vortexed,poured into a petri dish, coveredwitha microscope
coverslip, and incubated for 3 hours at 37◦C. The plaques
(representingantibodyformingB-lymphocytes)wereviewed
and quantiﬁed after this incubation. Results were expressed
as speciﬁc activity (IgM PFC per 106 spleen cells) and total
activity (IgM PFC per spleen).
2.9. Statistical Analysis. For analysis of the data generated
from the described animal studies, the data were ﬁrst tested
for homogeneity using the Bartlett’s Chi Square test. If
homogeneous, a one-way analysis of variance (ANOVA) was
conducted. If the ANOVA showed signiﬁcance at P<. 05
or less, the Dunnett’s Multiple Range t test was used to
compare treatment groups with the control group. Linear
trend analysis was performed to determine if PCBTF had
exposure concentration-related eﬀects for the speciﬁed end-
points. Statistical analysis was performed using Graph Pad
Prism version 5.0 (San Diego, CA). Statistical signiﬁcance is
designated by ∗(P ≤ .05) and ∗∗(P ≤ .01).
3.Results
3.1. In Vivo Studies Identiﬁed PCBTF to Be an Allergic Sensi-
tizer. Dermal exposure to PCBTF was not found to be toxic
atanyconcentrationtested(datanotshown).Forthisreason,
concentrations of PCBTF up to 100% were tested in the
subsequent studies. No ear swelling was observed in mice
after dermal exposure to PCBTF (Figure 2), suggesting that
PCBTFisnonirritating. DNFB(0.03%)wasusedasapositive
control for irritancy studies and resulted in an average
signiﬁcant increase of 84% in ear swelling after application
(data not shown). In the LLNA, dose-dependent (Linear
Trend test; P<. 01) increases in DLN proliferation were
observed after treatment with PCBTF, with counts from the
75% and 100% PCBTF exposed animals being signiﬁcantly
elevatedoverthe vehiclecontrolanimals (Figure 3).SI values
were 2.6, 5.3, and 5.3 for the 50%, 75%, and 100% exposure
groups, respectively. An EC3 value of 53.1% (Figure 3)w a s
calculated. HCA (30%) was used as a positive control for
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Figure 2: Ear swelling as a result of topical application of PCBTF.
Analysis of irritation after topical application of PCBTF. Bars
represent mean ± SE of 5 mice (10 ears) per group.
100 75 50 0
PCBTF (v/v) (%)
0
1000
2000
3000
d
p
m
/
2
n
o
d
e
s
EC3 = 53.1%
2.6
5.3
5.3
∗∗
∗∗
Figure 3: Allergic sensitization potential after dermal exposure to
PCBTF. Analysis of the allergic sensitization potential of PCBTF
using the LLNA. 3H-thymidine incorporation into draining lymph
node cells of BALB/c mice following exposure to vehicle or con-
centration of PCBTF. Numbers in boxes appearing above the bars
represent thestimulationindices foreach concentrationtested. Bars
represent mean ± SE of 5 mice per group. Levels of statistical
signiﬁcance are denoted ∗∗(P<. 01) as compared to acetone
vehicle.
these experiments and resulted in an average SI value of 24.5
(data not shown). Consistent with the LLNA results, PCBTF
exposure also signiﬁcantlyelevatedthecellularityoftheDLN
(Figure 4) following exposure to all concentrations.
3.2. Exposure to PCBTF Did Not Induce an Increase in Local
or Systemic IgE Levels. No changes in body or organ weights
were observed after exposure to PCBTF for these studies
(data not shown). The mechanisms of PCBTF sensitization
were further investigated using phenotypicanalysis ofB220+
and IgE+B220+ expressing cells in the DLNs and spleen. No
increases were observed in the B220+ cell or IgE+B220+ cell
populations (Table 1) in the DLN or spleen. No changes in
the percentage of CD4+ or CD8+ T cells in the DLN orJournal of Allergy 5
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Figure 4: Increased cellularity of DLN after PCBTF exposure.
Analysis of lymphocyte cellularity (cells/DLN) following exposure
to PCBTF. Bars represent means ± SE of5 mice per group. Levels of
statisticalsigniﬁcance are denoted as ∗(P ≤ .05) and ∗∗(P ≤ .01) as
compared to acetone vehicle.
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Figure 5: Lackof increasein serum IgE followingPCBTF exposure.
Analysis of total serum IgE after exposure to PCBTF. Bars represent
means ± SE of 5 mice per group.
spleen were observed after exposure to any concentration of
PCBTF (data not shown). Consistent with the IgE+B220+
results, exposure to PCBTF did not elevate total serum IgE
levels after exposure to any treatment groups (Figure 5).
Dermal exposure to the respiratory sensitizer TDI (1.5%)
signiﬁcantly elevated the B220+ (19.8 ± 2.3%) cell popula-
tion, IgE+B220+ (13.3 ± 2.8%) cell populations, and total
IgE (1587 ± 109ng/mL) levels (data not shown).
3.3. Exposure to PCBTF Increased Production of IFN-γ,b u t
Not IL-4 by Stimulated DLN Cells. Levels of IL-4 and IFN-γ
cytokine production by stimulated draining lymphoid cells
were analyzed to evaluate the eﬀect of PCBTF exposure
on Th1/Th2 balance. A dose-responsive (Linear Trend test;
P<. 01) increase in IFN-γ protein production by the DLN
was observed after dermal exposure to PCBTF. Signiﬁcant
elevations in cytokine production were observed at PCBTF
concentrations 50% and greater (Figure 6(a)). The maxi-
mum increase in INF-γ protein expression was calculated
to be 1,174 ± 169pg/mL. No signiﬁcant alterations in
IL-4 production were detected at any dose concentration
(Figure 6(b)). To conﬁrm the lack of Th2 cytokine induction
following PCBTF exposure, cytokine mRNA levels were
also analyzed in the DLNs of dermally exposed animals.
Consistent with the protein data, no increase in IL-4 or
IL-13 expression was observed (data not shown). Dermal
treatment with 1.5% TDI elevated IL-4 and IL-13 mRNA
expression in the DLN and signiﬁcantly enhanced IL-4
protein production by stimulated draining lymphoid cells
(496 ± 20pg/mL) (data not shown). The T-cell-mediated
sensitizer HCA (30%) signiﬁcantly elevated IFN-γ expres-
sion (2,122 ± 67pg/mL) (data not shown).
3.4. Dermal Exposure to PCBTF Did Not Alter the IgM Re-
sponse to SRBC. To evaluate immunosuppressive potential,
the murine splenic IgM response to SRBC was examined fol-
lowing a 14-day exposure to PCBTF. No changes in total
(PFC/spleen) or speciﬁc (PFC/106 cells) IgM antibody
activity to SRBC were observed after exposure to any con-
centration ofPCBTF (Figure 7). Animals exposed to thepos-
itive control, cyclophosphamide, had a signiﬁcantly reduced
speciﬁc spleen IgM response (67%) and total IgM response
(54%) compared to the acetone control animals. No changes
in body or organ weights were observed for these animals
(data not shown).
4.Discussion
More than 13 million workers in the United States are
potentially exposed to chemicals that can be absorbed
through the skin. Dermal exposure to chemicals in the
workplace has a great potential to aﬀect immune function.
Contact dermatitis is the second most commonly reported
occupational illness responsible for up to 30% of all cases
of occupational disease in industrialized nations [18]. This
may result in considerable social and economic implications,
includingtime oﬀfrom work, lossofworkplace productivity,
reduced quality of life, and medical and worker’s compensa-
tion costs, accounting for the loss of billions of dollars [19].
Results from these studies suggest that PCBTF is a weak
T-cell-mediated sensitizer. This was evidencedby an increase
in lymphocyte proliferation and IFN-γ protein production
by stimulated draining lymphoid cells, in the absence of
elevations in markers of IgE-mediated sensitization, such
as total IgE and IL-4 (mRNA and protein) production,
following dermal exposure in mice. The EC3 value for
PCBTF, 53.1%, falls within the working concentration for
this chemical, as it is used at concentrations up to 100% as
a solvent and as a chemical intermediate in the production
of other chemicals. This suggests a greater predicted risk
for worker sensitization. Immune suppression and other
immunotoxic eﬀectswere not observed after exposure to this
chemical.
Although exposure can occur through inhalation and
dermal contact during its production and use [2], there6 Journal of Allergy
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Figure 6: Increased IFN-γ protein production by DLN. Analysis of cytokine protein expression (a) IL-4 and (b) IFN-γ generated by
stimulated DLN after dermal exposed to PCBTF. Bars represent mean fold change ± SE of 5 mice per group. Levels of statistical signiﬁcance
are denoted as ∗(P<. 05) and ∗∗(P<. 01) as compared to acetone vehicle.
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Figure 7: PCBTF exposure does not alter the IgM response to SRBC. Analysis of antibody producing spleen cells after a 14-day dermal
exposure to PCBTF did not produce alternations in the total (a) and speciﬁc activity (b) IgM response to SRBC. Bars represent mean fold
change ± SE of 5 mice per group.
Table 1: Phenotypic analysis after in vivo PCBTF treatment.
Dose group IgE+B220+ (% lymphocyte population) B220+ (% lymphocyte population)
% Cells × 106 % Cells × 106
DLN
Acetone 1.1 ± 0.3 0.09 ± 0.02 11.5 ± 1.9 1.1 ± 0.16
PCBTF
50% 4.5 ± 2.1 0.13 ± 0.02 14.0 ± 3.1 2.0 ± 0.53
75% 3.5 ± 0.4 0.12 ± 0.02 12.6 ± 0.9 1.8 ± 0.24
100% 2.4 ± 0.6 0.14 ± 0.01 12.0 ± 1.4 1.8 ± 0.23
Spleen
Acetone 4.2 ± 2.4 2.1 ± 1.01 43.4 ± 4.7 2.3 ± 1.06
PCBTF
50% 4.7 ± 2.5 2.2 ± 1.33 38.9 ± 1.8 1.7 ± 1.12
75% 1.4 ± 0.1 1.7 ± 1.58 42.6 ± 1.7 1.9 ± 0.96
100% 2.2 ± 0.9 2.1 ± 0.98 40.1 ± 1.4 2.1 ± 1.21Journal of Allergy 7
are no standards in place to limit occupational exposure to
PCBTF [1]. For occupational exposures, an 8-hour time-
weighted average (TWA) permissible exposure level of
20ppm has been suggested by the Kowa American Corpora-
tion, the United States chemical importation company that
has renominated PCBTF for toxicological evaluation [1, 6].
In additional to occupational exposure, there is also the
potential for exposure of the general public through PCBTF-
containingproductsandPCBTFinandaroundgroundwater
[20]. Detectable levels of PCBTF have been identiﬁed in
workers (<1ppm)as well as wildlife (0.17–2.0ppm)[21, 22].
PCBTF is a halogenated solvent. These types of solvents
are usually considered more toxic to humans and usually
capable of causing greater environmental damage. Examples
of other halogenated solvents include trichloroethylene,
tetrachloroethylene, 1,1,1-trichloroethane, carbon tetrachlo-
ride, and dichloromethane. The majority of these solvents
are classiﬁed as carcinogens and central nervous system
depressants and can enter the body through respiratory
or dermal exposure [23]. In addition to the eﬀects to the
central nervous system, workplace exposure to many of these
solvents have been associated with toxic eﬀects in the liver
and kidney [24], as well as immune cell activation [25–31].
The eﬀects of PCBTF exposure on immune parameters are
consistent with those for other halogenated solvents, such as
trichloroethylene, which has been shown to enhance activa-
tionmarkersonandIFN-γ secretionbysplenic CD4+T-cells
[25–27]. Enhanced T-cell activation due to trichloroethylene
exposure has been demonstrated to enhance autoimmune-
related responses in both humans and mouse models [28,
29] .D u et ot h ew i d er a n g eo fh e a l t he ﬀects associated with
halogenated solvent exposure, occupational exposure limits
have been set for these compounds, which have resulted in
more stringent ventilation controls and personal protective
equipment use by workers.
5.Conclusion
Thesearetheﬁrststudiestoindentifythesensitizationpoten-
tial of PCBTF following dermal exposure. Results from these
studies indicate the importance of avoiding dermal contact
with PCBT, due to its potential to function as a T-cell-
mediated sensitizer and encourages the need to determine
appropriate PPE to prevent worker exposure.
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The ﬁndings and conclusions in this report are those of the
authors and do not necessarily represent the views of
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